Document resource
The competing interest statement of this article by Robert Howard and Helen Kales (BMJ 2023;382:p1852; doi:10.1136/bmj.p1852) has been amended to note that Robert Howard was an unpaid member of the scientific board of Synaptogenix. The article has now been recategorised as an Opinion.